Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors

The coronavirus disease 2019 (COVID-19) pandemic that has been ongoing since 2019 is still ongoing and how to control it is one of the international issues to be addressed. Antiviral drugs that reduce the viral load in terms of reducing the risk of secondary infection are important. For the general...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatematsu, Daiki, Akao, Marwa, Park, Hyeongki, Iwami, Shingo, Ejima, Keisuke, Iwanami, Shoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794526/
https://www.ncbi.nlm.nih.gov/pubmed/36586664
http://dx.doi.org/10.1016/j.jtbi.2022.111403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794526/
https://www.ncbi.nlm.nih.gov/pubmed/36586664
http://dx.doi.org/10.1016/j.jtbi.2022.111403

Ejemplares similares